Bergamot Polyphenols: Promising Agents for Health and Wellness
DOI:
https://doi.org/10.12775/JEHS.2024.65.009Keywords
citrus bergamia, bergamot polyphenols, hypercholesterolemia, anti-inflammatory, antioxidant activity, glucose-loweringAbstract
Introduction and purpose: Citrus bergamia, commonly known as bergamot, is a unique plant native to the Calabria region in Italy, prized for its fragrant fruits and versatile applications. Historically utilized for extracting essential oil, bergamot has garnered attention for its therapeutic properties, particularly its Bergamot-derived Polyphenolic Fraction (BPF), which exhibits lipid-lowering, antioxidant, and anti-inflammatory effects. This paper aims to provide a comprehensive summary of existing research on the therapeutic potential of BPF in humans.
Brief description of the state of knowledge: BPF has shown promise in supporting wound healing, alleviating neuropathic pain, and exhibiting antimicrobial properties. Research highlights BPF's role in modulating lipid metabolism, particularly in reducing LDL cholesterol and triglycerides while increasing HDL cholesterol levels. Additionally, BPF demonstrates anti-inflammatory effects, accelerating the recovery process in conditions such as non-alcoholic steatohepatitis (NASH) and potentially influencing pathways involved in cancer cell proliferation and apoptosis. Further studies explore BPF's impact on bone metabolism, erectile dysfunction, and its potential in dermatological applications, particularly in counteracting photoaging.
Conclusions: While existing studies underscore the promising therapeutic effects of BPF in various medical domains, further research is warranted to establish its efficacy and safety for broader clinical use. Continued investigation on a larger scale holds the potential to develop BPF as a valuable physiotherapeutic strategy across diverse medical fields.
References
Fratianni F, Cozzolino A, De Feo V, Coppola R, Ombra MN, Nazzaro F. Polyphenols, Antioxidant, Antibacterial, and Biofilm Inhibitory Activities of Peel and Pulp of Citrus medica L., Citrus bergamia, and Citrus medica cv. Salò Cultivated in Southern Italy. Molecules. 2019 Dec 13;24(24):4577. doi: 10.3390/molecules24244577. PMID: 31847295; PMCID: PMC6943604.
Navarra M, Mannucci C, Delbò M, Calapai G. Citrus bergamia essential oil: from basic research to clinical application. Front Pharmacol. 2015 Mar 2;6:36. doi: 10.3389/fphar.2015.00036. PMID: 25784877; PMCID: PMC4345801.
Mannucci, C., Navarra, M., Calapai, F., Squeri, R., Gangemi, S., & Calapai, G. (2016). Clinical Pharmacology of Citrus bergamia: A Systematic Review. Phytotherapy Research, 31(1), 27–39. doi:10.1002/ptr.5734
Currò M, Risitano R, Ferlazzo N, Cirmi S, Gangemi C, Caccamo D, Ientile R, Navarra M. Citrus bergamia Juice Extract Attenuates β-Amyloid-Induced Pro-Inflammatory Activation of THP-1 Cells Through MAPK and AP-1 Pathways. Sci Rep. 2016 Feb 8;6:20809. doi: 10.1038/srep20809. PMID: 26853104; PMCID: PMC4745106.
Quetglas-Llabrés MM, Quispe C, Herrera-Bravo J, Catarino MD, Pereira OR, Cardoso SM, Dua K, Chellappan DK, Pabreja K, Satija S, Mehta M, Sureda A, Martorell M, Satmbekova D, Yeskaliyeva B, Sharifi-Rad J, Rasool N, Butnariu M, Bagiu IC, Bagiu RV, Calina D, Cho WC. Pharmacological Properties of Bergapten: Mechanistic and Therapeutic Aspects. Oxid Med Cell Longev. 2022 Apr 25;2022:8615242. doi: 10.1155/2022/8615242. Retraction in: Oxid Med Cell Longev. 2024 Jan 9;2024:9849584. PMID: 35509838; PMCID: PMC9060977.
Han X, Beaumont C, Stevens N. Chemical composition analysis and in vitro biological activities of ten essential oils in human skin cells. Biochim Open. 2017 Apr 26;5:1-7. doi: 10.1016/j.biopen.2017.04.001. PMID: 29450150; PMCID: PMC5805555.
Ridouh I, Hackshaw KV. Essential Oils and Neuropathic Pain. Plants (Basel). 2022 Jul 7;11(14):1797. doi: 10.3390/plants11141797. PMID: 35890431; PMCID: PMC9323890.
Sanguinetti M, Posteraro B, Romano L, Battaglia F, Lopizzo T, De Carolis E, Fadda G. In vitro activity of Citrus bergamia (bergamot) oil against clinical isolates of dermatophytes. J Antimicrob Chemother. 2007 Feb;59(2):305-8. doi: 10.1093/jac/dkl473. Epub 2006 Nov 20. PMID: 17118937.
Stević T., Berić T., Šavikin K., Soković M., Gođevac D., Dimkić I., Stanković S. Antifungal activity of selected essential oils against fungi isolated from medicinal plant. Ind. Crop. Prod. 2014;55:116–122. doi: 10.1016/j.indcrop.2014.02.011.
Furneri PM, Mondello L, Mandalari G, Paolino D, Dugo P, Garozzo A, Bisignano G. In vitro antimycoplasmal activity of Citrus bergamia essential oil and its major components. Eur J Med Chem. 2012 Jun;52:66-9. doi: 10.1016/j.ejmech.2012.03.005. Epub 2012 Mar 11. PMID: 22465092.
Dosoky NS, Setzer WN. Biological Activities and Safety of Citrus spp. Essential Oils. Int J Mol Sci. 2018 Jul 5;19(7):1966. doi: 10.3390/ijms19071966. PMID: 29976894; PMCID: PMC6073409.
Maiuolo J, Carresi C, Gliozzi M, Musolino V, Scarano F, Coppoletta AR, Guarnieri L, Nucera S, Scicchitano M, Bosco F, Ruga S, Zito MC, Macri R, Cardamone A, Serra M, Mollace R, Tavernese A, Mollace V. Effects of Bergamot Polyphenols on Mitochondrial Dysfunction and Sarcoplasmic Reticulum Stress in Diabetic Cardiomyopathy. Nutrients. 2021 Jul 20;13(7):2476. doi: 10.3390/nu13072476. PMID: 34371986; PMCID: PMC8308586.
Nesci, S., Palma, E., Mollace, V. et al. Enjoy your journey: the bergamot polyphenols from the tree to the cell metabolism. J Transl Med 19, 457 (2021). https://doi.org/10.1186/s12967-021-03131-7
Elzbieta Janda, Antonella Lascala, Concetta Martino, Salvatore Ragusa, Saverio Nucera, Ross Walker, Santo Gratteri, Vincenzo Mollace, Molecular mechanisms of lipid- and glucose-lowering activities of bergamot flavonoids, PharmaNutrition http://dx.doi.org/10.1016/j.phanu.2016.05.001
R. Salerno, et al., Characterization of flavonoids in Citrus bergamia (Bergamot) polyphenolic fraction by liquid chromatography – high resolution mass spectrometry (LC/HRMS), PharmaNutrition (2015), http://dx.doi.org/10.1016/j.phanu.2015.10.001
Nauman MC, Johnson JJ. Clinical application of bergamot (Citrus bergamia) for reducing high cholesterol and cardiovascular disease markers. Integr Food Nutr Metab. 2019 Mar;6(2):10.15761/IFNM.1000249. doi: 10.15761/IFNM.1000249. Epub 2019 Feb 28. PMID: 31057945; PMCID: PMC6497409.
Mollace V, Sacco I, Janda E, Malara C, Ventrice D, Colica C, Visalli V, Muscoli S, Ragusa S, Muscoli C, Rotiroti D, Romeo F. Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies. Fitoterapia. 2011; 82 (3): 309–16.
Gliozzi M, Walker R, Muscoli S, Vitale C, Gratteri S, Carresi C, Musolino V, Russo V, Janda E, Ragusa S, Aloe A, Palma E, Muscoli C, Romeo F, Mollace V. Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia. International journal of cardiology. 2013; 170 (2): 140–5.
Toth PP, Patti AM, Nikolic D, Giglio RV, Castellino G, Biancucci T, Geraci F, David S, Montalto G, Rizvi A, Rizzo M. Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study. Frontiers in pharmacology. 2015; 6: 299.
Babish JG, Dahlberg CJ, Ou JJ, Keller WJ, Gao W, Kaadige MR, Brabazon H, Lamb J, Soudah HC, Kou X, Zhang Z, Pacioretty LM, Tripp ML. Synergistic in vitro antioxidant activity and observational clinical trial of F105, a phytochemical formulation including Citrus bergamia, in subjects with moderate cardiometabolic risk factors. Canadian journal of physiology and pharmacology. 2016; 94 (12): 1257–66.
Mollace V, Scicchitano M, Paone S, Casale F, Calandruccio C, Gliozzi M, Musolino V, Carresi C, Maiuolo J, Nucera S, Riva A, Allegrini P, Ronchi M, Petrangolini G, Bombardelli E. Hypoglycemic and Hypolipemic effects of a new lecithin formulation of Bergamot Polyphenolic Fraction: a double blind, randomized, placebo-controlled study. Endocrine, metabolic & immune disorders drug targets. 2018.
Mirarchi A, Mare R, Musolino V, Nucera S, Mollace V, Pujia A, Montalcini T, Romeo S, Maurotti S. Bergamot Polyphenol Extract Reduces Hepatocyte Neutral Fat by Increasing Beta-Oxidation. Nutrients. 2022 Aug 20;14(16):3434. doi: 10.3390/nu14163434. PMID: 36014938; PMCID: PMC9412422.
Cicero AFG, Fogacci F, Bove M, Giovannini M, Borghi C. Three-arm, placebo-controlled, randomized clinical trial evaluating the metabolic effect of a combined nutraceutical containing a bergamot standardized flavonoid extract in dyslipidemic overweight subjects. Phytother Res. 2019;33(8):2094–2101. doi: 10.1002/ptr.6402.
Rondanelli M, Peroni G, Riva A, Petrangolini G, Allegrini P, Fazia T, Bernardinelli L, Naso M, Faliva MA, Tartara A, Gasparri C, Infantino V, Perna S. Bergamot phytosome improved visceral fat and plasma lipid profiles in overweight and obese class I subject with mild hypercholesterolemia: A randomized placebo controlled trial. Phytother Res. 2021 Apr;35(4):2045-2056. doi: 10.1002/ptr.6950. Epub 2020 Nov 13. PMID: 33188552; PMCID: PMC8246838.
Mollace, Vincenzo; Scicchitano, Miriam; Paone, Sara; Casale, Francesca; Calandruccio, Carla; Gliozzi, Micaela; Musolino, Vincenzo; Carresi, Cristina; Maiuolo, Jessica; Nucera, Saverio; Riva, Antonella; Allegrini, Pietro; Ronchi, Massimo; Petrangolini, Giovanna; Bombardelli, Ezio. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Volume 19, Number 2, 2019, pp. 136-143(8) DOI: https://doi.org/10.2174/1871530319666181203151513
Walker, R., Janda, E., & Mollace, V. (2014). The Use of Bergamot-Derived Polyphenol Fraction in Cardiometabolic Risk Prevention and its Possible Mechanisms of Action. Polyphenols in Human Health and Disease, 1087–1105. doi:10.1016/b978-0-12-398456-2.00084-0
Meizlish ML, Franklin RA, Zhou X, Medzhitov R. Tissue Homeostasis and Inflammation. Annu Rev Immunol. 2021 Apr 26;39:557-581. doi: 10.1146/annurev-immunol-061020-053734. Epub 2021 Mar 2. PMID: 33651964.
Gulcin İ. Antioxidants and antioxidant methods: an updated overview. Arch Toxicol. 2020 Mar;94(3):651-715. doi: 10.1007/s00204-020-02689-3. Epub 2020 Mar 16. PMID: 32180036.
Russo, C.; Lombardo, G.E.; Bruschetta, G.; Rapisarda, A.; Maugeri, A.; Navarra, M. Bergamot Byproducts: A Sustainable Source to Counteract Inflammation. Nutrients 2024, 16, 259. https://doi.org/10.3390/nu16020259
Parafati, M.; Lascala, A.; La Russa, D.; Mignogna, C.; Trimboli, F.; Morittu, V.M.; Riillo, C.; Macirella, R.; Mollace, V.; Brunelli, E.; et al. Bergamot Polyphenols Boost Therapeutic Effects of the Diet on Non-Alcoholic Steatohepatitis (NASH) Induced by “Junk Food”: Evidence for Anti-Inflammatory Activity. Nutrients 2018, 10, 1604. https://doi.org/10.3390/nu10111604
Adorisio S, Muscari I, Fierabracci A, Thi Thuy T, Marchetti MC, Ayroldi E, Delfino DV. Biological effects of bergamot and its potential therapeutic use as an anti-inflammatory, antioxidant, and anticancer agent. Pharm Biol. 2023 Dec;61(1):639-646. doi: 10.1080/13880209.2023.2197010. PMID: 37067190; PMCID: PMC10114982.
Navarra, M., Femia, A. P., Romagnoli, A., Tortora, K., Luceri, C., Cirmi, S., … Caderni, G. (2019). A flavonoid-rich extract from bergamot juice prevents carcinogenesis in a genetic model of colorectal cancer, the Pirc rat (F344/NTac-Apcam1137). European Journal of Nutrition. doi:10.1007/s00394-019-01948-z
Jiang Y, Nguyen TV, Jin J, Yu ZN, Song CH, Chai OH. Bergapten ameliorates combined allergic rhinitis and asthma syndrome after PM2.5 exposure by balancing Treg/Th17 expression and suppressing STAT3 and MAPK activation in a mouse model. Biomed Pharmacother. 2023 Aug;164:114959. doi:10.1016/j.biopha.2023.114959. Epub 2023 May 31. PMID: 37267637.
Lerner UH, Ohlsson C. The WNT system: background and its role in bone. J Intern Med. 2015 Jun;277(6):630-49. doi: 10.1111/joim.12368. PMID: 25845559.
Pujia, A.; Russo, C.; Maurotti, S.; Pujia, R.; Mollace, V.; Romeo, S.; Montalcini, T. Bergamot Polyphenol Fraction Exerts Effects on Bone Biology by Activating ERK 1/2 and Wnt/β-Catenin Pathway and Regulating Bone Biomarkers in Bone Cell Cultures. Nutrients 2018, 10, 1305. https://doi.org/10.3390/nu10091305
Leslie SW, Sooriyamoorthy T. Erectile Dysfunction. 2024 Jan 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 32965924.
V. Mollace, et al., Bergamot polyphenolic fraction counteracts erectile dysfunction occurring in patients suffering from type 2 diabetes, PharmaNutrition (2016), http://dx.doi.org/10.1016/j.phanu.2015.11.006
Gentile P, Garcovich S. Adipose-Derived Mesenchymal Stem Cells (AD-MSCs) against Ultraviolet (UV) Radiation Effects and the Skin Photoaging. Biomedicines. 2021 May 11;9(5):532. doi: 10.3390/biomedicines9050532. PMID: 34064624; PMCID: PMC8151305.
S.P. Nisticò, et al., Bergamot polyphenolic fraction counteracts photoageing in human keratinocytes, PharmaNutrition (2015), http://dx.doi.org/10.1016/j.phanu.2015.11.004
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Dariusz Gruca, Marcin Wais, Marlena Zając, Paweł Zalewski, Wiktor Wróblewski, Adam Raabe
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 304
Number of citations: 0